Riskpilot← Back to searchSign inGet full accessSN Medinfo AB
ABActiveOrg 5568733488Kallsövägen 39General medical practice activities · NACE 8621Est. 20111 employees
Revenue 2025
SEK 348K
+48% vs 2024
EBITDA margin
94.4%
+58% vs 2024
Equity ratio
43.8%
Financial strength
Net profit 2025
SEK 237K
+34% vs 2024
| Revenue | SEK 348K | +48% |
| EBITDA | SEK 328K | +58% |
| Net profit | SEK 237K | +34% |
| Total assets | SEK 1,2M | +28% |
| Equity | SEK 534K | +13% |
| Employees | 1 | — |
Legal name
SN Medinfo AB
Org number
5568733488
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
28 november 2011
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall försälja tjänster inom medicinsk information, kommunikation och utbildning jämte sjukvård, forskning och utveckling samt förvalta fast och lös egendom, och därmed förenlig verksamhet.
Address
Kallsövägen 39
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 274 | 233 | 553 | 234 | 348 |
| Staff expenses | — | −11 | −33 | −8 | −4 |
| EBITDA | 201 | 157 | 441 | 207 | 328 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 201 | 157 | 441 | 207 | 328 |
| Net financials | −4 | 0 | 2 | 4 | −0 |
| Profit before tax | 152 | 117 | 331 | 227 | 302 |
| Tax | −31 | −25 | −69 | −50 | −65 |
| Net profit | 121 | 92 | 262 | 177 | 237 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 745 | 813 | 1 147 | 952 | 1 219 |
| Equity | 392 | 384 | 545 | 472 | 534 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 128 | 164 | 223 | 117 | 296 |
| Total debt | 128 | 164 | 223 | 117 | 296 |
EBITDA margin
94.4%
This company
15.8%
Market median
+497% vs market
20212025
Equity ratio
43.8%
This company
38.2%
Market median
+15% vs market
20212025
Return on equity
44.4%
This company
18.4%
Market median
+141% vs market
20212025
Net profit margin
68.1%
This company
8.1%
Market median
+741% vs market
20212025
Asset turnover
0.29×
This company
1.12×
Market median
-74% vs market
20212025
Debt / equity
1.28×
This company
0.62×
Market median
-106% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SN Medinfo AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sam Axel Nordfeldt | Board of Directors | 0 companies |
| Örjan Gunnar Ljungberg | Deputy Board Member | 0 companies |